$2.30
-0.03 (-1.29%)
Open$2.33
Previous Close$2.33
Day High$2.34
Day Low$2.30
52W High$3.61
52W Low$2.09
Volume—
Avg Volume29.9K
Market Cap71.04M
P/E Ratio—
EPS$-1.32
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+420.4% upside
Current
$2.30
$2.30
Target
$11.97
$11.97
$8.96
$11.97 avg
$15.34
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 51.54M | 48.92M | 53.08M |
| Net Income | -6,374,638 | -6,659,114 | -5,888,081 |
| Profit Margin | -12.4% | -13.6% | -11.1% |
| EBITDA | -7,191,271 | -7,364,625 | -7,497,793 |
| Free Cash Flow | -8,326,283 | -5,338,476 | -7,416,749 |
| Rev Growth | +3.4% | -7.2% | +0.9% |
| Debt/Equity | 0.61 | 0.70 | 0.59 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |